ATE82502T1 - Zusammensetzungen zur vorbeugung von plastikabstossung. - Google Patents

Zusammensetzungen zur vorbeugung von plastikabstossung.

Info

Publication number
ATE82502T1
ATE82502T1 AT87108976T AT87108976T ATE82502T1 AT E82502 T1 ATE82502 T1 AT E82502T1 AT 87108976 T AT87108976 T AT 87108976T AT 87108976 T AT87108976 T AT 87108976T AT E82502 T1 ATE82502 T1 AT E82502T1
Authority
AT
Austria
Prior art keywords
rejection
heparin
compositions
humans
preventing plastic
Prior art date
Application number
AT87108976T
Other languages
English (en)
Inventor
Irun Cohen
Israel Vlodavsky
Amiram Eldor
Yaakov Naparstek
Original Assignee
Hadassah Med Org
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hadassah Med Org, Yeda Res & Dev filed Critical Hadassah Med Org
Application granted granted Critical
Publication of ATE82502T1 publication Critical patent/ATE82502T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Transplantation (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Fertilizers (AREA)
  • Soil Working Implements (AREA)
  • Paper (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT87108976T 1986-06-26 1987-06-23 Zusammensetzungen zur vorbeugung von plastikabstossung. ATE82502T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IL79254A IL79254A0 (en) 1986-06-26 1986-06-26 Compositions for preventing graft rejection
EP87108976A EP0251134B1 (de) 1986-06-26 1987-06-23 Zusammensetzungen zur Vorbeugung von Plastik-Abstossung

Publications (1)

Publication Number Publication Date
ATE82502T1 true ATE82502T1 (de) 1992-12-15

Family

ID=11056896

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87108976T ATE82502T1 (de) 1986-06-26 1987-06-23 Zusammensetzungen zur vorbeugung von plastikabstossung.

Country Status (10)

Country Link
EP (1) EP0251134B1 (de)
JP (1) JP2527749B2 (de)
AT (1) ATE82502T1 (de)
AU (1) AU608228B2 (de)
DE (1) DE3782686T2 (de)
DK (1) DK169422B1 (de)
ES (1) ES2052514T3 (de)
GR (1) GR3006814T3 (de)
IL (1) IL79254A0 (de)
NO (1) NO872675L (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5541166A (en) * 1987-01-23 1996-07-30 The Australian National University Sulphated polysaccharides having anti-metastatic and/or anti-inflammatory activity
IL85145A (en) * 1987-01-23 1994-08-26 Univ Australian Anti-metastatic pharmacological or veterinary preparations containing modified herpin with reduced anticoagulant activity
GB8808810D0 (en) * 1988-04-14 1988-05-18 Biopharm Clinical Research Ltd Heparin-containing formulations
IL86753A0 (en) * 1988-06-15 1988-11-30 Hadassah Med Org Pharmaceutical compositions for treatment of lupus
DE3821271A1 (de) * 1988-06-23 1989-12-28 Solco Basel Ag Derivatisiertes heparin, verfahren zu dessen herstellung und arzneimittel, welches dieses enthaelt
IL88554A0 (en) * 1988-12-01 1989-07-31 Hadassah Med Org Compositions containing a compound binding to a heparin receptor
US5158940A (en) * 1990-02-14 1992-10-27 The United States Government As Represented By The Secretary, Dhhs Use of suramin to treat rheumatologic diseases
AU756279B2 (en) * 1997-07-14 2003-01-09 Medical Therapies Limited Agents comprising Midkine or its inhibitor as active ingredient
US6538028B1 (en) 2000-02-01 2003-03-25 Vanderbilt University Method for inhibiting complement activation
CN1197587C (zh) * 2000-06-09 2005-04-20 中国科学院上海细胞生物学研究所 N－位脱硫酸肝素在预防和治疗炎症中的应用
CZ307433B6 (cs) 2001-09-12 2018-08-22 Leadiant Biosciences Sa Deriváty částečně desulfátovaných glykosaminoglykanů jako inhibitory heparanázy mající antiangiogenní účinky a zabraňující antikoagulačnímu působení
PL1748781T3 (pl) 2004-05-27 2013-05-31 Baxter Int Sposoby do leczenia zaburzeń związanych z krwawieniem z zastosowaniem siarczanowanych polisacharydów
AU2009284393B2 (en) 2008-08-22 2014-09-25 Takeda Pharmaceutical Company Limited Methods for treating bleeding disorders
US8632991B2 (en) 2010-01-14 2014-01-21 Baxter International Inc. Methods and compositions for treating bleeding disorders
EP3417865A1 (de) 2011-07-19 2018-12-26 Baxalta GmbH Resorptionsförderer als additive zur verbesserung der oralen formulierung nicht-antikoagulierender sulfatierter polysaccharide
US9417251B2 (en) 2012-08-14 2016-08-16 Baxalta GmbH Methods and systems for screening compositions comprising non-anticoagulant sulfated polysaccharides
ES2732659T3 (es) 2013-03-12 2019-11-25 Baxalta GmbH Potenciadores de la resorción como aditivos para mejorar la formulación oral de heparinas de bajo peso molecular
SE538503C2 (en) 2014-11-11 2016-08-16 Tx Medic Ab New dextran sulfate
JP6887628B2 (ja) * 2015-06-11 2021-06-16 ユニフェルシテイト マーストリヒトＵｎｉｖｅｒｓｉｔｅｉｔ Ｍａａｓｔｒｉｃｈｔ 被移植体における移植不全を防ぐ方法
EP4518857A4 (de) * 2022-05-06 2026-04-15 Bargent Therapeutics Pty Ltd Verfahren zur behandlung von allotransplantatabstossung

Also Published As

Publication number Publication date
NO872675L (no) 1987-12-28
JP2527749B2 (ja) 1996-08-28
EP0251134A3 (en) 1989-05-03
DK169422B1 (da) 1994-10-31
NO872675D0 (no) 1987-06-25
JPS6388127A (ja) 1988-04-19
AU7470687A (en) 1988-01-07
EP0251134A2 (de) 1988-01-07
GR3006814T3 (de) 1993-06-30
IL79254A0 (en) 1986-09-30
EP0251134B1 (de) 1992-11-19
AU608228B2 (en) 1991-03-28
DE3782686T2 (de) 1993-06-09
DK331287D0 (da) 1987-06-26
DE3782686D1 (de) 1992-12-24
ES2052514T3 (es) 1994-07-16
DK331287A (da) 1987-12-27

Similar Documents

Publication Publication Date Title
DE3782686D1 (de) Zusammensetzungen zur vorbeugung von plastik-abstossung.
DE3587266D1 (de) Verfahren und system zur entfernung von immunosuppressiven bestandteilen aus saeugetierblut.
ATE122542T1 (de) Essbare plastische dispersion.
DE10199020I1 (de) Galanthamin oder dessen Analoge zur Behandlung der Alzheimerschen Krankheit
AU5841090A (en) Sulphated polysaccharides, anticoagulant agent and anticomplementary agent obtained from brown algae fucuses and method of obtaining same
ATE60924T1 (de) Verfahren zur kontrollierten herstellung von glykosaminoglykanen mit niedrigem molekulargewicht.
DE3382716D1 (de) Verfahren zur Wärmebehandlung von Plasma oder Plasmafraktionen und so erhaltene Zusammensetzungen.
DE69328438D1 (de) Eichenrindenextraktverwandte synthetische zubereitungen und verfahren zur verwendung
ES2070116T3 (es) Peptidos que inhiben la union del factor von willebrand.
ATE10340T1 (de) Stabilisierung der aktivitaet des faktors viii im blutplasma.
EP0335901A4 (en) Methods and compositions for the treatment of non-ige-mediated diseases
DE3584560D1 (de) Arzneimittelzusammensetzung geeignet zur behandlung oder prophylaxe von herzstoerungen.
DE69027220D1 (de) Zusammensetzung und verfahren zur behandlung von schmerzvollen entzündlichen oder allergischen erkrankungen
EP0376251A3 (en) An anticoagulant substance obtained from urine
SE9002550D0 (sv) Heparinfragment
EP0058397A3 (de) Antikoagulans und seine Verwendung
ATE113591T1 (de) 4-benzyl-5-phenyl-2,4-dihydro-3h-1,2,4-triazol- - one und ihre verwendung als antikonvulsiva.
BG97199A (bg) Антикоагулантен препарат
FI873428A7 (fi) Silmälääketieteelliset koostumukset hermodegeneraatioiden hoitoon.
SE8802193L (sv) Utvaertes anvaendbar, antiviral farmaceutisk komposition som ackumuleras i huden samt foerfarande foer framsttaellning av densamma
ATE92322T1 (de) Verwendung von benzothiazepin-derivaten, insbesondere diltiazem zur herstellung von arzneimitteln zur protektion von lymphozyten.
DE3775278D1 (de) Topische methotrexatzubereitung zur behandlung hyperproliferativer epithelerkrankungen.
DE69919578D1 (de) VERWENDUNG von NIEDERMOLEKULAREM HEPARIN zur Behandlung und/oder Prophylaxe motoneuronaler Krankheiten
ES2062754T3 (es) Eliminacion de linfocitos activados.
DE59003111D1 (de) Arzneimittel und ihre Verwendung zur Behandlung von Parasitosen.

Legal Events

Date Code Title Description
EEIH Change in the person of patent owner
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee